Nemaura Medical Inc. Business Finance Contracts & Agreements
26 Contracts & Agreements
- Credit Agreements (1 contract)
- Equity Distribution Agreements (1)
- Loan Agreements (1)
- Note Agreements (9)
- Purchase Agreements (3)
- Security Agreements (4)
- Subscription Agreements (1)
- Warrant Agreements (6)
- Security Agreement, entered into on November 16, 2023 and dated as of November 14, 2023, executed by the registrant, Dermal Diagnostics Limited and Trial Clinic Limited in favor... (Filed With SEC on November 21, 2023)
- Secured Promissory Note issued by the registrant, Dermal Diagnostics Limited and Trial Clinic Limited in favor of Streeterville Capital, LLC (Filed With SEC on November 21, 2023)
- Line of Credit Agreement, entered into on November 16, 2023 and dated as of November 14, 2023, by and among the registrant, Dermal Diagnostics Limited, Trial Clinic Limited, and... (Filed With SEC on November 21, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on January 31, 2023)
- Form of Warrant (Filed With SEC on January 31, 2023)
- Security Agreement, dated as of May 20, 2022, by and among Nemaura Medical Inc., Dermal Diagnostics Limited and Trial Clinic Limited (Filed With SEC on November 14, 2022)
- Secured Promissory Note, dated as of May 20, 2022, issued by Nemaura Medical Inc (Filed With SEC on November 14, 2022)
- Note Purchase Agreement, dated as of May 20, 2022, by and among Nemaura Medical Inc., Dermal Diagnostics Limited, and Trial Clinic Limited and Streeterville Capital, LLC (Filed With SEC on November 14, 2022)
- Amendment to Secured Promissory Note, dated as of October 21, 2022, by and among Nemaura Medical Inc., Dermal Diagnostics Limited, Trial Clinic Limited and Uptown Capital, LLC (Filed With SEC on October 26, 2022)
- Security Agreement between the Registrant and Uptown Capital, LLC dated February 8, 2021 (Filed With SEC on February 11, 2021)
- Secured Promissory Note of the Registrant issued to Uptown Capital, LLC dated February 8, 2021 (Filed With SEC on February 11, 2021)
- Note Purchase Agreement between the Registrant and Uptown Capital, LLC dated February 8, 2021. (Please note that portions of this exhibit have been omitted) (Filed With SEC on February 11, 2021)
- Warrant Agency Agreement, dated July 30, 2020, by and between Nemaura Medical Inc. and Nevada Agency & Trust Company (Filed With SEC on July 30, 2020)
- Form of Warrant (Filed With SEC on July 30, 2020)
- Security Agreement dated April 15, 2020 by the registrant, Dermal Diagnostics Limited and Trial Clinic Limited, in favor of Chicago Venture Partners, L.P (Filed With SEC on April 21, 2020)
- Investor Note #2 dated April 15, 2020 issued by Chicago Venture Partners, L.P. in favor of the registrant, Dermal Diagnostics Limited and Trial Clinic Limited (Filed With SEC on April 21, 2020)
- Investor Note #1 dated April 15, 2020 issued by Chicago Venture Partners, L.P. in favor of the registrant, Dermal Diagnostics Limited and Trial Clinic Limited (Filed With SEC on April 21, 2020)
- Secured Promissory Note dated April 15, 2020 issued by the registrant in favor of Dermal Diagnostics Limited, Trial Clinic Limited and Chicago Venture Partners, L.P (Filed With SEC on April 21, 2020)
- Note Purchase Agreement dated April 15, 2020 by and among the registrant, Dermal Diagnostics Limited, Trial Clinic Limited, and Chicago Venture Partners, L.P (Filed With SEC on April 21, 2020)
- Loan Agreement, dated July 31, 2019, by and between the Company and Carter Gem Properties Limited (Filed With SEC on August 9, 2019)
- Warrant Agency Agreement by and between Nemaura Medical Inc. and Island Stock Transfer dated December 20, 2018 (Filed With SEC on December 26, 2018)
- Unit Purchase Option (Filed With SEC on December 26, 2018)
- Form of Warrant (Filed With SEC on December 26, 2018)
- Equity Distribution Agreement, dated as of October 19, 2018, by and between Nemaura Medical, Inc. and Maxim Group LLC (Filed With SEC on October 19, 2018)
- NEMAURA MEDICAL INC. WARRANT (Filed With SEC on December 2, 2015)
- SUBSCRIPTION AGREEMENT (Filed With SEC on December 2, 2015)
